HIGHLIGHTS
- who: Jui-Ling Yu and colleagues from the Department of Data Science and Big Data Analytics, Providence University, Taichung City, Taiwan have published the paper: Exploring the Interactions of Oncolytic Viral Therapy and Immunotherapy of Anti-CTLA-4 for Malignant Melanoma Mice Model, in the Journal: Cells 2023, 12, 507. of /2023/
- what: The authors propose a mathematical model to explore the interactions of combined of viruses and a checkpoint inhibitor anti-CTLA-4. The aims of the proposed model are to predict: combining oncolytic virotherapy with immune checkpoint modulators would reduce tumor burden by . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.